1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Heather Wakelee: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) Erlotinib hydrochloride, Dovitinib lactate - Non-small Cell Lung Cancer (NSCLC), Recurrent, Non-small Cell Lung Cancer (NSCLC), Stage IV | Phase 1 | Terminated | Heather Wakelee | 9 | 2012-07-01 | 2016-07-12 |
Carcinoma, Non-Small-Cell Lung (1) · Recurrence (1)
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one (1) · Erlotinib Hydrochloride (1) · Receptor Protein-Tyrosine Kinases (1)
United States (1)